fbpx

Lloyd Diamond new CEO of BONESUPPORT

 

Lund, Sweden; Lloyd Diamond has been recruited CEO of BONESUPPORT – the Swedish medical technology company with a revolutionary orthobiologic platform for treatment of osteoporotic fractures and deep bone infections. Mr. Diamond replaces Dr. Fredrik Lindberg, the co-founder and present CEO, who will remain in the company as Chief Scientific Officer.

By the recruitment of Lloyd Diamond BONESUPPORT is taking the next step in accelerating the commercialization of its Cerament oesteoconductive bone substitute. There is strong support and a firm commitment from the owners to build a world class company within the segment for injectable orthobiologics.

Lloyd’s very strong international experience from the device industry, including spine and orthopedics, will help us accelerate our ambitions to grow the company. I am very pleased that we have attracted Lloyd to join us with his solid commercial and operational background”, says Oern Stuge, Chairman of BONESUPPORT.

I am very excited about joining BONESUPPORT – an innovative high-tech company which has developed top class products based on solid scientific evidence. In addition, the company has an exciting pipeline of future orthobiologic products“, says Mr. Diamond.

Mr.Diamond has held positions in the medical device industry with leading global companies such as Laserscope, Kyphon and Conmed Linvatec; formerly Zimmer when it was a subsidiary of Bristol-Myers Squibb. He most recently served as the President Lumenis EMEA. Previously Mr. Diamond served as Sr. VP and General Manager of Lumenis’ Surgical and Vision businesses. He holds a BS Degree in Biochemistry and Marketing, as well as a Masters in Business Administration from Thunderbird School of Global Management in Arizona. Mr. Diamond will commence his new position at BONESUPPORT on Jan 16, 2012.

Fredrik Lindberg, co-founder and current CEO will remain in the company as Chief Scientific Officer being responsible for key customer relations, driving the clinical publication program as well as the product development pipeline for “the first of its kind” products for the treatment and prophylaxis of deep bone and orthopedic prosthesis infections.
As a co-founder I am very pleased to get the chance to work with Lloyd. With his background from commercial operations within the international medtech industry I am convinced BONESUPPORT will expand more rapidly in the international market””, says Fredrik Lindberg.

For additional information, feel free to call:

Oern Stuge, Chairman of BONESUPPORT, +41 796 58 51 20
Lloyd Diamond, +46 46 286 53 79
Fredrik Lindberg, CEO
+46 708 86 53 70
Press photos are available at www.bonesupport.com

BONESUPPORT
BONESUPPORTAB is an innovative Swedish medical technology company that specializes in the development of high-tech solutions for the treatment of osteoporotic fractures and deep bone infections. Founded in 1999, the company is headquartered at Ideon Science Park in Lund, Sweden. BONESUPPORT has subsidiaries in the United States, Netherlands and Germany. Its key trademark is CERAMENTT.

Nyheder

Syv forskningsinstitutioner får 20 mio. kr. til corona-forskning
1. april 2020
Sådan håndterer vi ændring af forskningsprojekter under corona-pandemien
31. marts 2020
Første Corona-bevilling fra Lundbeckfonden til forsøg med et kendt lægemiddel
26. marts 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge